oxyPharma

Tirzepatide OXY-TIRZE (10 mg) OxyPharma

Name: Tirzepatide OXY-TIRZE (10 mg) OxyPharma
Brand: oxyPharma

0 customer reviews

Price on request

Tirzepatide 10 mg: an innovative approach to treating type 2 diabetes and weight loss Tirzepatide 10 mg is a unique solution for patients seeking not only to improve blood sugar control, but also to manage body weight. This drug is developed for the treatment of type 2 diabetes and is based on the dual action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues. Both hormones regulate glucose levels and appetite, making tirzepatide a promising treat

● Out of stock

SKU: tirzepatide-oxy-tirze-10-mg-oxypharma-default
Brand: oxyPharma
Category: Peptides

Tirzepatide is a dual GIP/GLP-1 receptor agonist that combines the action of two incretin hormones in a single peptide. By stimulating insulin secretion after meals and suppressing glucagon secretion between meals, it supports both post-meal and fasting blood sugar stability while also acting on appetite centers to reduce hunger. This OxyPharma vial contains 10 mg of Tirzepatide for reconstitution and subcutaneous use.

This dual mechanism gives Tirzepatide a stronger overall metabolic effect than single-pathway peptides, supporting significant, gradual weight loss alongside improved glycemic control and cardiovascular support.

Key Benefits

Dual GIP/GLP-1 action for stronger glycemic and appetite control than single-receptor peptides
Suppresses appetite and increases satiety, supporting gradual weight loss
Stabilizes blood glucose both after meals and between meals
Supports cardiovascular health markers relevant to metabolic patients
Mid-size 10 mg vial matches common mid-to-target titration doses